Key result
Each additional left atrial functional substrate linked to ~90% greater AF recurrence risk post-PVI.
Why the study?
The authors investigated the association between left atrial functional abnormal findings on high-resolution substrate maps and AF recurrence in patients undergoing pulmonary vein isolation without additional substrate ablation.
Do left atrial functional abnormal findings on high-resolution mapping predict atrial fibrillation recurrence in patients undergoing a second pulmonary vein isolation?
Observational (n=100)
No
Do left atrial functional abnormal findings on high-resolution mapping predict atrial fibrillation recurrence in patients undergoing a second pulmonary vein isolation?
Effect estimate: HR 1.90 (95% CI 1.44-2.52)
p-value: p=<0.00001
High-resolution mapping identifies left atrial functional substrates that cumulatively predict atrial fibrillation recurrence after pulmonary vein isolation.
Left atrial functional substrates on mapping may stratify AF recurrence risk after PVI; leaves open whether substrate modification improves outcomes.
Background Low-voltage areas have been used as atrial structural substrates in estimating fibrotic degeneration in patients with atrial fibrillation (AF). The high-resolution maps obtained by recently developed mapping catheters allow the visualization of several functional abnormalities. Objectives We investigated the association between left atrial (LA) functional abnormal findings on a high-resolution substrate map and AF recurrence in patients who underwent pulmonary vein isolation without any additional LA substrate ablation. Methods One hundred consecutive patients who underwent second ablation for AF (paroxysmal, 48%; persistent, 52%) were considered for enrollment. Patients with extra-pulmonary-vein LA substrate ablation during the initial and second ablation were excluded. LA mapping was performed using a 64-pole mini-basket catheter on the Rhythmia mapping system. Patients were followed for 2 years. Results AF recurrence developed in 39 (39%) patients. On the high-resolution substrate map, AF recurrence was associated with the presence of the following findings: low-voltage areas (<1.0 mV, >5cm 2 ; hazard ratio [HR]=2.53; 95% confidence interval [CI]=1.30-4.93; p<0.006), fractionated-electrogram areas (≥5 peaks, >5cm 2 ; HR=2.15, 95%CI=1.10-4.19; p=0.025), LA conduction time of >130 msec (HR=3.11, 95%CI=1.65-5.88, p<0.0001), deceleration zone (≥5 isochrones/cm 2 ; HR=1.97, 95%CI=1.04-3.37, p=0.039), and multiple septal breakout points (HR=3.27, 95%CI=1.50-7.16, p=0.003). Accumulation of these risk factors increased AF recurrence in a stepwise manner, with an HR=1.90, 95%CI=1.44-2.52, p<0.00001 for each additional risk factor. Conclusion A high-resolution map revealed new LA functional substrates associated with AF recurrence. Implementation of functional substrates may improve the prediction of AF recurrence after ablation, and possibly aid the development of tailored AF ablation strategies. Graphical abstract Abnormal LA substrates and accumulation of risk factors Study design, representative maps demonstrating abnormal substrates, and AF recurrence rates stratified by the number of risk factors are shown. Accumulation of these risk factors increased AF recurrence rates in a stepwise manner with an HR = 1.90, 95% CI = 1.44 - 2.52, p<0.00001, for 1 risk increase. AF indicates atrial fibrillation; HR, hazard ratio; CI, confidence interval.
No takes yet. Share an insight, caveat, or question.
Masuda et al. (2023) conducted an observational in Atrial fibrillation (n=100). Presence of left atrial functional substrates on high-resolution mapping vs. Absence of left atrial functional substrates was evaluated on Atrial fibrillation recurrence (HR 1.90, 95% CI 1.44-2.52, p=<0.00001). The accumulation of left atrial functional substrates on high-resolution mapping increased the risk of atrial fibrillation recurrence after pulmonary vein isolation, with an HR of 1.90 for each additional risk factor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: